Clinical Report: The Role of Natural Compounds in Bone Health and Disorders

Overview

This editorial discusses the role of natural compounds in bone health, particularly in the context of osteoporosis and related disorders.

Background

Osteoporosis represents a significant global health challenge, contributing to millions of deaths and disability-adjusted life years, particularly among postmenopausal women, as indicated by the Global Burden of Disease Study 2021. Current pharmacotherapies can have adverse effects, necessitating the exploration of natural compounds as alternative or adjunctive treatments.

Data Highlights

No numerical data provided in the source material, which limits the ability to quantify the impact of natural compounds on bone health.

Key Findings

• Natural products may offer multi-target therapeutic advantages for bone health, as supported by various studies.
• Flavonoids, terpenoids, and polysaccharides can alleviate oxidative stress in osteoblasts, according to recent research.
• Vitamin K2 supplementation significantly affects bone turnover markers in osteoporosis patients, as shown in a systematic review.
• Tocotrienols may protect osteocytes from oxidative stress and apoptosis, based on current findings.
• Herbal compounds can influence the gut microbiota, impacting joint and bone health, as discussed in recent literature.

Clinical Implications

Clinicians should consider the role of dietary and herbal supplements in managing bone health, particularly in patients with chronic skeletal diseases, based on emerging evidence.

Conclusion

Further investigation into the mechanisms and clinical efficacy of natural compounds in the treatment of bone disorders is warranted.

Related Resources & Content

1. Zhang et al., Frontiers in Endocrinology, 2025 -- The effect of vitamin K2 supplementation on bone turnover biochemical markers in postmenopausal osteoporosis patients: a systematic review and meta-analysis
2. Zahanordin et al., Frontiers in Medicine, 2026 -- The Role of Nutraceuticals and Natural Substances in Chronic Disease Management
3. NOGG 2024: Clinical guideline for the prevention and treatment of osteoporosis
4. Frontiers in Endocrinology — Editorial: Molecular and cellular mechanisms of bone remodeling
5. Frontiers in Endocrinology — Editorial: Emerging therapies for metabolic bone diseases
6. Frontiers in Immunology — The role of gut microbiota in osteoporosis: underlying mechanisms, clinical associations, and emerging biomaterials
7. Final Recommendation Statement: Osteoporosis to Prevent Fractures: Screening | United States Preventive Services Taskforce
8. Guide Bone Healthy Diet - Bone Health & Osteoporosis Foundation
9. NOGG 2024: Clinical guideline for the prevention and treatment of osteoporosis
10. Calcium, vitamin D, or combined supplementation to prevent fractures and falls: systematic review and meta-analysis - PMC
11. The impact of probiotics and synbiotics supplementation on bone health; an umbrella review of systematic reviews and meta-analysis - PubMed
12. Frontiers | The effect of vitamin K2 supplementation on bone turnover biochemical markers in postmenopausal osteoporosis patients: a systematic review and meta-analysis
13. Effects of Isoflavone Interventions on Bone Metabolism in Perimenopausal and Postmenopausal Women: An Umbrella Review of Meta-Analyses of Randomized Controlled Trials - ScienceDirect